USANA (USNA) Q1 2026: Omnichannel Sales Jump to 20% of Total, Driving Platform Transformation
USANA’s Q1 results underscore an accelerating shift from single-channel direct sales to a diversified omnichannel health platform. The quarter saw sequential improvement in core nutrition, surging omnichannel segment contribution, and early signs of international and retail expansion traction. With omnichannel brands now tracking toward a fifth of total sales, USANA’s evolving strategy is reshaping its growth profile and risk mix for 2026 and beyond.
Summary
- Omnichannel Surge: Non-direct sales brands now represent a rapidly expanding share of total revenue.
- Platform Leverage: Integration across R&D, supply chain, and retail partnerships is driving operational efficiencies.
- Strategic Execution: Leadership is doubling down on tech modernization and product pipeline to sustain multi-segment growth.
Business Overview
USANA Health Sciences operates as a global health and wellness company, generating revenue through a mix of direct sales and omnichannel distribution. Its business is organized into three segments: the core nutritional business (direct sales, primarily in Asia), Hiya (direct-to-consumer children’s health brand, expanding into retail), and Rise Wellness (active nutrition, with products like Protein Pop and Rise Bar sold through major U.S. retailers). The company’s revenue model is now a blend of traditional distributor-driven sales and fast-growing omnichannel (retail and DTC, direct-to-consumer) channels.
Performance Analysis
USANA delivered sequential improvement in its core nutrition segment, with net sales of $204 million driven by active customer growth—especially in China, which benefited from Lunar New Year acquisition activity. Management highlighted that stabilization efforts, including a refreshed brand partner compensation plan and accelerated product launches, are beginning to take hold. Notably, omnichannel brands Hiya and Rise Wellness contributed a combined $46 million in Q1 sales, up sharply from prior periods and now tracking to more than 20% of 2026 total net sales (up from just 1% two years ago).
Hiya posted $32 million in net sales with 186,000 active subscribers, reflecting modest sequential improvement despite ongoing customer acquisition cost (CAC) headwinds tied to Meta advertising disruptions. The brand’s international and retail launches (Canada, UK, Target) are early but promising. Rise Wellness delivered $14 million in net sales, an eightfold increase year-over-year, fueled by Protein Pop’s national debut at Costco and growing retail placements at Walmart and Target. Margin commentary indicates that in-house manufacturing and ERP integration are expected to drive incremental efficiencies in the back half of the year.
- Omnichannel Expansion: Hiya and Rise Wellness are now a material growth engine, with retail and DTC formats broadening USANA’s reach and risk profile.
- Core Stability: Sequential customer growth and product innovation are stabilizing the legacy nutrition business, with China showing resilience.
- Margin Leverage: Operational integration and in-house production are positioned to unlock cost advantages as omnichannel scales.
The quarter marks a visible inflection in USANA’s revenue composition, with omnichannel momentum counterbalancing legacy channel cyclicality and setting the stage for a multi-segment growth trajectory.
Executive Commentary
"Our first quarter results reflect USANA's continued and deliberate transformation from a single-channel direct sales business to a diversified omni-channel health and wellness platform. That evolution is the defining story of this company right now, and the progress we are making across our three business segments reinforces our confidence that this strategy will deliver sustained compounding value over time."
Kevin Guest, Chairman and Chief Executive Officer
"Omnichannel net sales are on track to represent more than 20% of the total net sales this year, up from 16% in 2025, and approximately 1% just two years ago. That trajectory speaks to how quickly our omnichannel platform is taking shape."
Kevin Guest, Chairman and Chief Executive Officer
Strategic Positioning
1. Omnichannel Acceleration
USANA’s pivot to omnichannel is fundamentally altering its growth profile, with Hiya and Rise Wellness now central to future expansion. Retail and DTC penetration are providing new vectors for customer acquisition, geographic expansion, and brand diversification—diluting reliance on direct sales and unlocking new addressable markets.
2. Product Innovation and R&D Integration
Product pipeline velocity is increasing, with over 20 new products in development spanning women’s health, children’s health, gut health, and active nutrition. Cross-segment R&D and learnings from omnichannel brands are being leveraged to refresh the core product suite and respond to evolving consumer demand, especially around protein and weight management trends.
3. Operational Synergy and Margin Focus
Bringing Hiya and Rise Wellness manufacturing in-house, implementing a new ERP system, and centralizing supply chain management are expected to drive incremental margin efficiency. These moves also create a platform for scalable growth and operational resilience as new brands and channels are onboarded.
4. International and Retail Channel Expansion
Hiya’s launches in Canada, the UK, and Target, plus Rise Wellness’s rapid rollout to Costco, Walmart, and nine additional U.S. retailers, demonstrate execution speed and the ability to penetrate new markets through both digital and physical retail.
5. Technology Modernization
Investment in IT and digital infrastructure is being prioritized, with incremental spending funded by operational efficiency gains rather than new capital outlays. This modernization aims to enhance customer experience and drive future cost leverage.
Key Considerations
The quarter’s results highlight USANA’s evolving risk and opportunity set as it moves beyond its legacy direct sales roots. Investors should weigh the implications of a more complex, multi-channel model on growth, margin, and capital allocation.
Key Considerations:
- Channel Diversification: Omnichannel now drives a fifth of sales, reducing exposure to direct sales cyclicality but introducing new retail and DTC risks.
- Margin Dynamics: In-house manufacturing and ERP integration are positioned to offset higher CAC and retail margin pressures over time.
- Product Pipeline: Over 20 new products in development, with a focus on women’s, children’s, gut, and active nutrition, could drive segment growth and cross-channel synergy.
- Geographic Expansion: Early traction in Canada and Target for Hiya, with UK and further U.S. retail launches representing future growth levers.
- Customer Acquisition Costs: Meta advertising headwinds remain a watchpoint, but efforts to diversify marketing channels are underway.
Risks
USANA’s transformation introduces execution risk across new channels, geographies, and product categories. Retail sell-through, CAC volatility, and international market ramp are all sources of potential short-term volatility. The shift to omnichannel increases operational complexity, while core direct sales stability remains critical to funding growth investments. Management’s guidance assumes continued operational discipline and successful integration of new brands and systems, but any misstep could pressure margins or dilute focus.
Forward Outlook
For Q2 2026, USANA expects:
- Continued sequential improvement in core nutrition customer counts
- Omnichannel brands to accelerate as new retail doors and international markets scale
For full-year 2026, management reaffirmed guidance:
- Consolidated net sales of $925 million to $1 billion
- Hiya net sales of $140 million to $155 million
Management emphasized that incremental tech modernization will be funded through operational efficiencies and that omnichannel net sales will surpass 20% of total revenue this year.
- Omnichannel expansion remains a top priority
- Product innovation and international launches are expected to drive H2 acceleration
Takeaways
USANA’s Q1 marks a strategic inflection, with omnichannel brands now a core growth engine and operational integration supporting future margin expansion.
- Omnichannel Scale: Hiya and Rise Wellness are reshaping USANA’s revenue mix and risk profile, providing new growth levers independent of the legacy direct sales channel.
- Platform Synergy: R&D, manufacturing, and digital modernization are being leveraged across segments to drive both innovation and cost efficiency.
- Watchpoints: Investors should monitor retail sell-through, international market ramp, and margin realization from operational investments as omnichannel scales.
Conclusion
USANA’s Q1 2026 results confirm a decisive pivot from single-channel legacy to a multi-segment, omnichannel health platform. With omnichannel brands on track to deliver over 20% of total sales, operational integration and product innovation are now central to the company’s long-term growth and margin narrative.
Industry Read-Through
USANA’s rapid omnichannel expansion and integration of direct-to-consumer and retail brands signal a broader structural shift in the health and wellness sector. The blending of legacy direct sales with retail and digital-first models is likely to raise competitive intensity and accelerate product innovation across the industry. Margin management through vertical integration and supply chain control is emerging as a key differentiator. Companies reliant on single-channel models may face increasing pressure to diversify, while those investing in digital infrastructure and R&D will be best positioned to capitalize on evolving consumer preferences and retail dynamics.